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Summary
Objectives: We established a pilot sentinel surveillance system for Neisseria gonorrhoeae
infection in Tainan to evaluate underreporting in the National Gonorrhea Notifiable Disease
System (NGNDS), and also conducted a survey to understand physicians’ specific reasons for
underreporting in the Tainan region.
Methods: A sentinel surveillance network consisting of six specialty clinics was created in Tainan
City. Three hundred seventeen patients who were clinically diagnosed with urethritis, cervicitis,
or gonorrhea were enrolled. N. gonorrhoeae infection was detected by urine-based PCR. A
questionnaire was mailed to healthcare providers who potentially see patients with gonorrhea in
the Tainan region.
Results: Forty-eight N. gonorrhoeae-positive subjects were identified from the sentinel surveil-
lance, and none of these gonorrhea cases were notified to the NGNDS by their healthcare
providers. During the study period, there were 67 notified cases in the NGNDS, depicting an
underestimation of at least 42% for this epidemic. Of the 16 healthcare providers who had seen
cases in the past 3 months, only seven (43.8%) reported that they notified the authorities and only
23 (32%) of 71 cases were reported. ‘Not collecting a specimen’ and ‘afraid of the invasion of
patient privacy by the authorities’ were the main reasons for the lack of notification.
§ The results of this study were presented in part at the 16th International Society for Sexually Transmitted Diseases Research Meeting, July
2005, Amsterdam, the Netherlands.
* Corresponding author. Current address: Johns Hopkins University Department of Emergency Medicine, 5801 Smith Avenue, Suite 3220 Davis
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Conclusions: The underreporting of gonorrhea identified in this pilot is substantial. An overhaul of
Taiwan’s NGNDS that streamlines the reporting procedures and the requirement for laboratory
confirmation, along with a continuing medical education program is warranted.
# 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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According to the Taiwan Centers for Disease Control’s (CDC)
National Notifiable Diseases Surveillance System (NNDSS),
cases of confirmed gonorrhea, a notifiable communicable
disease in Taiwan for more than five decades, and not to
mention one of the most neglected diseases, has rapidly
increased more than five-fold, from 362 in the year 2000
(1.62 cases per 100 000 population) to 1981 in the year 2004
(8.73 cases per 100 000 population).1 It is widely believed
that this statistic, which is well below figures for the USA,2
England and Wales,3 Canada, and Australia,4 hardly repre-
sents the true epidemic of gonorrhea in Taiwan. It is specu-
lated that underreporting from medical providers is one of
the main reasons for the underestimation of gonorrhea in
Taiwan.
Gonorrhea is a class III notifiable disease in Taiwan, which
is a disease that requires notification to the local health
authorities within oneweek, with a laboratory confirmation.1
Culture is themain laboratory method for confirmation of this
disease. Refusal of the invasive urethral or cervical sample
collection method for culture by both patients and health-
care providers results in the unavailability of laboratory
confirmation. Thus, many clinically diagnosed gonorrhea
cases are disqualified from notification to the health autho-
rities.
With the advent of nucleic acid amplification tests
(NAATs) for the detection of genital Neisseria gonorrhoeae
infection during the late 1990 s,5 an increase in the use of
confirmation assays using a non-invasive sample collection
method (urine for both sexes or self-administered vaginal
swab for females) is likely. This could potentially increase
the likelihood of healthcare provider reporting of gonorrhea
cases. A better understanding of current gonorrhea epi-
demics is more likely to be unveiled. In addition, little
information is available on the attitudes of local healthcare
professionals to the National Gonorrhea Notifiable Disease
System (NGNDS) as well as their practices and willingness to
report.
Therefore, we conducted a pilot study with two aims:
(1) to evaluate the underreporting to the NGNDS and (2) to
understand the reasons for the underreporting by physi-
cians. Two approaches were employed to assess the mag-
nitude of underreporting. One was to use NAATs to detect
N. gonorrhoeae infection in patients with clinically diag-
nosed urethritis, cervicitis, or gonorrhea but without cul-
ture confirmation. This approach identifies additional
gonorrhea cases that do not then require notification to
the authorities. The other method was to survey health-
care providers regarding numbers of clinically diagnosed
gonorrhea cases that they have encountered and notified in
the last 3 months. This approach identifies cases that fail
to be confirmed by laboratory methods and/or fail to be
notified.Materials and methods
Study population
Since 1995, Taiwan has had a universal health insurance
program,6 with a coverage rate of >97% in 2002.7 People
in Taiwan can access and utilize health facilities and special-
ties with maximum freedom and without the need for a
referral from their general practitioner.8
The Tainan region, located on the southwestern coast of
Taiwan main island, consists of one metropolitan city —
Tainan City — two municipalities, and 29 townships, with a
population of 1.85 million. The medical care facilities are
concentrated in Tainan City, the chief city with six adminis-
trative districts and a population of 700 000 in an area of 176
square kilometers. Tainan City is served by two medical
centers, 20 hospitals, 95 general practice clinics, 48 family
medicine clinics, 74 internal medicine clinics, 38 obstetrics
and gynecology clinics, 16 dermatology clinics, and six urol-
ogy clinics,9 which could all possibly encounter patients with
urethritis, cervicitis, or gonorrhea. No public funded sexually
transmitted diseases (STDs) clinics operate here and patients
with STDs usually visit community-based clinics first. Since
the early 2000 s, this area has been the third leading area in
gonorrhea case notification in Taiwan.10
Study design
Pilot sentinel physician network
Twenty clinics were selected from the complete list of 108
urology, obstetrics and gynecology, dermatology, family
medicine, and internal medicine clinics in Tainan City
based on geographic location, i.e., administrative district
of the clinics, specialty, and known popular clinics for
urethritis, cervicitis, or gonorrhea recommended by a
panel of experienced local physicians. These 20 clinics
were further approached for their willingness to be parti-
cipants in the sentinel network through individual inter-
view. All of them were made aware of the NGNDS when
they were invited to participate in our study. Among them,
physicians of one urology, one dermatology, two family
medicine, and two obstetrics and gynecology clinics who
expressed strong interest in our study during our visits to
their clinics were invited to participate in the pilot phy-
sician-based sentinel surveillance on urethritis, cervicitis,
and gonorrhea. These six clinics, which are privately
owned, are geographically located in four districts of
Tainan City and their patients come from all six districts
as well as neighboring townships. Reasons given for the 14
clinics that declined to participate in the pilot sentinel
surveillance network included ‘not interested’, ‘too busy’,
and their ‘business will be affected’.
The case definition for patient enrollment in this pilot was
clinically diagnosed urethritis, cervicitis, or gonorrhea by
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was based on clinician’s day in, day out practice and labora-
tory tests such as urinalysis, the leukocyte esterase test,
Gram staining, or culture for N. gonorrhoeae, performed at
the clinical discretion of the clinicians. NAATs for the detec-
tion of genital N. gonorrhoeae infection were not used in
these clinics. The pilot was conducted for 30 weeks, from
October 20, 2003 to May 2004. During the study period, the
physician providers or nurses at participating sites were
requested to approach all patients with clinically diagnosed
urethritis, cervicitis, or gonorrhea to participate in this
study. After informed consent was obtained, consenting
patients were then asked to provide the first void urine
specimen in a 15-ml sterile centrifuge tube. Urine specimens
were stored at 4 8C in the clinic before being transported to
the laboratory by the study research assistant. No individual
identifiers were collected.
Research assistants called at each participating clinic
every day to communicate with each site regarding specimen
collection, supply of tubes and labels, and issues related to
the pilot surveillance system. In addition, laboratory results
were periodically reported back to the participating health-
care providers via telephone call. At the end of the study
period, the total number of gonorrhea cases notified to the
NGNDS from each site during the study period was requested
by the research assistant.
Provider survey
An anonymous questionnaire was designed to understand the
factors affecting the reporting of gonorrhea cases to the
NGNDS from the point of view of local physicians. The
absence of public STD clinics in this area prompted the study
to mail the questionnaires to all clinics and hospitals where
patients with gonorrhea-like or urogenital symptoms may
seek medical care. These included clinics that specialize in
urology (n = 19), obstetrics and gynecology (n = 86), derma-
tology (n = 34), family medicine (n = 111), internal medicine
(n = 161), general practice (n = 235), and infectious diseases
(n = 8) in the Tainan region.
Survey instruments were designed to collect knowledge
and perceptions of healthcare providers regarding gonorrhea
as a notifiable disease. Information was collected on themost
recent encounter and reporting of gonorrhea cases to the
health authorities in the last 3months (categorized as 0, 1—3,
4—6, 7—9,10 cases, or ‘do not know’), the reasons/barriers
for not reporting, and their suggestions to the health autho-
rities pertaining to potential resolutions. Due to the anon-
ymity of the survey, only the provider’s specialty was
collected in the questionnaire.
Laboratory methods
Urine specimens were transported to the laboratory within
24 hours and were aliquoted as 1-ml samples before being
stored at  80 8C. DNA extraction from each aliquot sample
was undertaken before the PCR assay, using a DNA extraction
kit (Viogene, Taiwan). An in-house multiplex PCR was per-
formed on the DNA-extracted urine specimens to detect the
presence of N. gonorrhoeae and Chlamydia trachomatis
infection simultaneously.11 This assay was designed to target
and amplify the conserved region of the cppB gene of N.
gonorrhoeae. Spiked N. gonorrhoeae and C. trachomatispositive controls and negative controls were included in each
run of DNA extraction steps through to PCR assay. PCR
amplicons were analyzed by agarose gel electrophoresis
and stained with ethidium bromide, then visualized under
UV light. This in-house multiplex PCR has a sensitivity of
97.3% and a specificity of 100% for the detection of N.
gonorrhoeae in first void urine specimens.11
Ethical considerations
The study protocol was approved by the Institutional Review
Board of the National Cheng Kung University College of
Medicine.
Data analysis
A descriptive data analysis was performed on the surveillance
data as well as the questionnaire data.
Pilot sentinel physician network
A patient in the pilot sentinel physician network was
defined as an underestimated gonorrhea case if he/she
was clinically diagnosed with urethritis, cervicitis, or
gonorrhea, and was N. gonorrhoeae-positive by the in-
house PCR. The degree of underestimation of gonorrhea
cases was measured by underestimated gonorrhea cases
over sum of notified cases and underestimated cases during
the study period.
Provider survey
Estimated numbers of gonorrhea cases diagnosed and notified
in the past 3 months were reported as 0, 1—3, 4—6, 7—9 or
10 cases by respondents. The ranges of potential gonorrhea
cases encountered and notified were estimated by calculat-
ing the lower and upper limit of case numbers in each
category, then multiplying by the total number of respon-
dents in each category. The degree of underreporting of
gonorrhea cases in the past 3 months among respondents
was defined as estimated un-notified gonorrhea cases over
estimated total diagnosed gonorrhea cases.
Results
Pilot sentinel physician network
N. gonorrhoeae-positive cases from the sentinel
physician network
Over the 7-month study period, 317 patients with clinically
diagnosed urethritis, cervicitis, or gonorrhea were
recruited from the sentinel physician network and their
urine specimens were tested for N. gonorrhoeae. The
majority of enrollees were female (n = 228, 71.9%).
Approximately 70% (n = 220) of the subjects were enrolled
from two obstetrics and gynecology clinics, followed by the
dermatology (n = 59) and the urology clinic (n = 36). Only
two cases were identified and enrolled from two family
medicine clinics. Four participating sites refused to pro-
vide the total number of cases that they encountered
during the study period due to issues of confidentiality
at their practices. Therefore, the participation rate among
cases was not available.
Table 1 Comparison of the number of notified gonorrhea cases and Neisseria gonorrhoeae infections detected by the physician
sentinel surveillance network, Tainan region, Taiwan, 2003—2004
Month/year Week
numbers
Gonorrhea notified
cases in the NGNDS
database
N. gonorrhoeae
infection detected
by physician sentinel
surveillance
Oct. 2003 43—44 1 0
Nov. 2003 45—48 15 2
Dec. 2003 49—52 9 16
Jan. 2004 1—5 11 7
Feb. 2004 6—9 11 3
Mar. 2004 10—14 9 9
Apr. 2004 15—18 10 10
May 2004 19—20 1 1
Total 67 48
NGNDS, National Gonorrhea Notifiable Disease System.
Table 2 Number of clinically diagnosed gonorrhea cases by
the number of respondents in the past 3 months from the
provider survey in Tainan region, Taiwan, 2003—2004
Clinically
diagnosed
gonorrhea
cases
Number of
respondents
(%)
Estimated
gonorrhea
cases (range)
0 70 (76.1) 0
1—3 8 (8.7) 16 (8—24)
4—6 5 (5.4) 25 (20—30)
7—9 0 (0) 0
10 3 (3.3) 30
Unknown 6 (6.5) Unknown
Total 92 71 (58—84)
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The positivity rates by specific clinical diagnosis and gender
were 52.8% (47/89) for males with a diagnosis of urethritis,
19.0% (4/21) for females with urethritis, 1.5% (3/202) for
females with cervicitis, and 0% (0/5) for females with both
urethritis and cervicitis. Most of the PCR-positive cases were
patients from internal medicine/urology/dermatology
(n = 26) and the urology clinic (n = 24). Forty-eight (88.9%)
N. gonorrhoeae-positive patients resided in the Tainan
region. The numbers of positive cases by week as well as
the official notified gonorrhea cases in the NGNDS database in
this region are summarized in Table 1. At the end of the pilot,
none of the participating sites stated that they had reported
any gonorrhea cases to the NGNDS during the study period.
Underestimation of gonorrhea cases
Through the sentinel physician surveillance network, 48
individuals who were clinically diagnosed with urethritis,
cervicitis, or gonorrhea had a genital gonococcal infection
identified by PCR. None of these 48 cases were reported to
the NGNDS. During the same period of time, 67 gonorrhea
cases were reported to the NGNDS in the Tainan region
(Table 1). The total number of gonorrhea cases during the
study period would be at least 115 if the 48 cases from the
sentinel physician surveillance network were included.
Therefore, the rate of underestimation of cases was 42%
(48/115).
Provider survey
Recognition of gonorrhea as a notifiable disease
Overall, the questionnaire response rate was 14.1% (92/654)
after two mailings. None of the 235 general practice clinic
providers returned the survey. The response rate was 22.0% if
general practice clinic providers were excluded. The major-
ity of respondents weremale (77.2%), physicians (75.0%), and
practicing at private clinics (73.9%). More than a third of
physician responders were family medicine physicians
(36.2%), followed by internal medicine physicians (33.3%).
Only 75% (69/92) of the respondents correctly answered that
gonorrhea is in fact a notifiable disease. Approximately two
thirds (63.0%, 58/92) correctly stated that gonorrhea is aclass III notifiable disease and that a laboratory confirmation
is required for reporting.
Experience of diagnosing and reporting gonorrhea cases
Sixteen (17.4%) respondents had clinically diagnosed at least
one gonorrhea case in the past 3 months (Table 2). Eight
participants stated that they had diagnosed 1—3 cases, five
have seen 4—6 cases, and the remaining three individuals had
diagnosed over 10 cases. Based on their responses, an estima-
tion of at least 58—84 gonorrhea cases were clinically diag-
nosed by these 16 participants in the past 3 months. However,
only 43.8% (7/16) of these respondents had reported gonor-
rhea cases to the NGNDS. Four respondents stated that they
had notified 1—3 cases of gonorrhea to the Taiwan CDC and
three had reported 4—6 cases. Based on these numbers, an
estimate of at least 16—30 gonorrhea cases were notified
(Table 3). According to the data from the questionnaires, on
average, the provider-perceived gonorrhea notification rate
was 32% (23/71) with a range of 19% (16/84) to 52% (30/58)
during the study period (Tables 2 and 3).
Reasons associated with not reporting gonorrhea cases
The majority (62.0%, 57/92) of the questionnaire respon-
dents stated that they had never had a patient with gonor-
Table 3 Number of notified gonorrhea cases to the National
Gonorrhea Notifiable Disease System by respondents in the
past 3 months from the provider survey in the Tainan region,
Taiwan, 2003—2004
Notified
gonorrhea
cases
Number of
respondents
(%)
Estimated
notified
gonorrhea
cases (range)
0 77 (83.7) 0
1—3 4 (4.3) 8 (4—12)
4—6 3 (3.3) 15 (12—18)
7—9 0 (0) 0
10 0 (0) 0
Unknown 8 (8.7) Unknown
Total 92 23 (16—30)
Underreporting of gonorrhea in Tainan, Taiwan e417rhea. The main reasons for not reporting gonorrhea cases
among those who had clinically diagnosed patients with
gonorrhea were ‘do not collect specimens’ (14.3%, 5/35)
and ‘afraid of the invasion of patient privacy by the autho-
rities’ (14.3%, 5/35), followed by ‘did not know it is notifi-
able’ (11.4%, 4/35).
However, respondents expressed a willingness to improve
the reporting of gonorrhea if the health authorities could
improve some factors that they have concerns about. The
leading factors were ‘ensuring the protection of patient
privacy’ (40.2%, 37/92) and ‘subsidizing laboratory diagnosis’
(40.2%, 37/92), followed by ‘providing materials for labora-
tory diagnosis’ (38.0%, 35/92) and ‘providing guidance for
correct specimen collection’ (31.5%, 29/92).
Discussion
Results from this pilot sentinel surveillance study indicate
that a syndromic-based sentinel surveillance that utilizes
urine-based PCR for the detection of genital gonococcal
infection uncovers a hidden epidemic of gonorrhea outside
of the NGNDS in Tainan, Taiwan. At least 40% of the under-
estimations pertaining to the gonorrhea cases were revealed
under the current requirement protocol and provider prac-
tice for notification, i.e., invasive urethral or cervical sample
collection method for culture confirmation. Furthermore,
the main reasons for the underreporting of clinically diag-
nosed gonorrhea cases were clearly identified. Issues related
to the requirement of specimen collection for laboratory
confirmation were ranked highest. Surprisingly, some provi-
ders in the provider survey were not aware that gonorrhea is
in fact a notifiable disease.
A substantial number of medical providers in our survey
were unaware of the required notification of gonorrhea
cases. The case-reporting rate was well below the satisfac-
tory level, even though it is legally mandated. This finding is
consistent with the results from a national survey of US
physicians.12,13 In that study, slightly over a quarter of all
respondents were unaware of the requirement for reporting
gonorrhea. In practice, less than 50% of survey respondents
reported gonorrhea cases to the health authorities and 41% of
the respondents never reported them. Medical providers
were unaware of the legal mandate for notification or theychose not to report even if they knew about the legal
requirement. Others have suggested reasons for the under-
reporting of gonorrhea, including the provider’s view of a
lack of benefit for both the provider and the patient on case-
reporting on STD control, resistance from patients, perceived
violation of the doctor—patient confidential relationship,
expectation of rewards on reporting, and the perceived
cumbersome time-consuming bureaucratic administrative
procedures.14 In our study, only those reasons for under-
reporting from the provider’s point of view that were based
on personal practice experience over a number of cases were
examined. Reasons for underreporting from the patient’s
point of view, which were not investigated in this study,
are also valuable since they are more individualized and
personal, especially with regard to confidentiality, stigmati-
zation, and sample collection methods. Further research is
needed to address these issues in order to overcome the
barriers to reporting.
In Taiwan, the requirement of laboratory confirmation
adds another obstacle to the reporting process. Three of
the leading four areas that the health authorities could
improve to increase provider willingness to report gonorrhea
cases are related to ‘the requirement of laboratory confir-
mation’. Most of the current practices still use the culture
method, which requires invasive specimen collection (Taiwan
CDC, personal communication). In addition, this requirement
has also developed into a loophole for not notifying gonor-
rhea cases to the health authorities for physicians who might
choose not to collect specimens for culture. This type of
practice undoubtedly will affect the true picture of the
epidemic. One method to prevent this from happening is
to create an additional tier in the reporting system that is
specifically designed for clinically diagnosed gonorrhea cases
only. Or, another approach is to promote the use of NAATs as
an alternative laboratory confirmation test, which would
eliminate the invasiveness of sample collection. However,
it appears that most providers are not familiar with NAATs.
Therefore, coupling this with a streamlining of the specimen
collection protocol and technical, material supplement, and
monetary incentives for laboratory diagnosis, could decrease
the underreporting of clinically diagnosed gonorrhea cases.
As with the current practice of culture confirmation, labora-
tory confirmation by NAATs is not likely to be performed at
clinics or regional hospitals. Specimens from clinics could be
sent to the public health laboratories or licensed contracted
hospital laboratories and NAATs could be performed at these
facilities; periodical training of laboratory staff will be
needed and they will be required to receive larger quantities
of specimens and to be sustained financially.
In this study, we utilized NAATs to detect the hidden
gonorrhea epidemic in patients who were clinically diag-
nosed with urethritis, cervicitis, or gonorrhea. The urine-
based or self-administered vaginal swab collection methods
are more acceptable and the preferred specimen collection
method for patients.15—17 In Taiwan, this type of assay has
been introduced, however, it is not as common as in other
developed countries.18,19 If NAATs are promoted as an alter-
native laboratory confirmation test using non-invasive speci-
men collection methods as mentioned above, a more reliable
estimate of the true epidemic of gonorrhea will be unveiled
after the increased use of laboratory confirmation followed
by case notification.
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system may potentially miss the emergence of increased N.
gonorrhoeae incidence and also its resistance to antibiotic
treatment. In our study, none of the N. gonorrhoeae PCR-
positive patients were notified to the NGNDS. The ‘passive’
nature of the national notifiable disease reporting system
may result in the under-representation of the true STD
incidence by 50% or more.20 An add-on of an ‘active’ sentinel
surveillance system consisting of motivated physicians should
achieve a significantly better quality of reporting and cap-
turing of the incidence of this disease and the emergence of
antibiotic resistance. Thus, this addition may better serve
gonorrhea disease control and prevention.
One of the major limitations of the physician-based sen-
tinel surveillance in our study was the relatively small num-
ber of sentinel sites. Yet, our pilot study demonstrated the
feasibility of physician-based sentinel surveillance for gonor-
rhea and uncovered substantial underestimation of the
gonorrhea epidemic in the area. Another limitation was
the unavailability of the total number of clinically diagnosed
cases in four out of six participating sites. This means that the
data may have been evaluated less comprehensively.
Through personal communication with each site, the parti-
cipation rate estimated by each site was ‘average’, ‘moder-
ate’ or ‘not poor’, which could translate as greater than 50%
rather than in the low 20 s or less. In addition, the total
number of enrollees during the 7-month study period also
supports our estimation, which is unlikely to be in the low 20 s
or less. However, we do not have hard numbers to support
this. Another possible limitation is that the case definition for
enrollment was purely based on clinical diagnosis. It is
possible that there was a wide-range of diagnosis variation
across the providers at the participating sites because of
their experience and specialty training. Nevertheless, we
still identified an underestimation rate of 42% from our pilot
physician-based sentinel surveillance, indicating the actual
number will be even higher.
One of the major limitations of the provider survey was
the low response rate (14.1%), corresponding to a similar
survey study to primary care physicians in Germany.21 There-
fore, our findings from the provider survey are probably not
generalizable. Two reasons for the non-response to our ques-
tionnaire might include ‘patients with gonorrhea rarely
encountered’ and ‘lack of interest in gonorrhea’. It is likely
due to their rare encounters with this type of patient. In the
Tainan region, there are no public STD clinics available.
Individuals with STD-like symptoms, if they decide to seek
regular medical care, will have to go to a general clinic or
hospital that specializes in general family medicine, internal
medicine, or perhaps those that specialize in urology or
gynecology. Therefore, we mailed our survey questionnaire
to all clinics or hospitals that have the possibility of encoun-
tering patients with symptoms of gonorrhea. It is likely that
most of the non-respondents did not encounter or rarely
cared for patients with such symptoms. Therefore, our
results still demonstrate a high percentage of underreporting
of gonorrhea cases among those who encounter this type of
patient frequently, even if the actual underreporting of
gonorrhea in this area remains unrevealed. Of note, none
of the general practice clinic providers, consisting of 35% of
our survey population, returned the survey. Among the sur-
veyees, they are least likely to encounter patients of interestin this study and might have had little interest in our survey.
The response rate went up to 22% if this group of providers
was excluded.
In conclusion, the pilot ‘active’ sentinel physician sur-
veillance system, coupledwith the use of non-invasive NAATs
technology, revealed the presence of underestimation and
underreporting of the hidden epidemic of gonorrhea. Fac-
tors of underreporting by providers were also identified in
this study. We believe our study provides further evidence
that an improved national notifiable disease system may be
achieved by comprehensively improving medical education
and continuing medical education on the notifiable diseases
system. The need for public health disease control should be
fulfilled by incorporating NAATs technology to confirm geni-
tal gonococcal infection, and streamlining the reporting
procedures from the provider’s side. An overhaul of Taiwan’s
NGNDS to better reflect the true epidemic of gonorrhea is
warranted.
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